These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 9300265

  • 1. Distribution of S(-)-zacopride-insensitive [125I]R(+)-zacopride binding sites in the rat brain and peripheral tissues.
    Ge J, Barnes JM, Towers P, Barnes NM.
    Eur J Pharmacol; 1997 Aug 13; 332(3):307-12. PubMed ID: 9300265
    [Abstract] [Full Text] [Related]

  • 2. Characterisation of the non-5-HT3 high-affinity 'R' binding site for (R)-zacopride in brain and other tissues.
    Kidd FJ, Levy JC, Nielsen M, Hamon M, Gozlan H.
    Eur J Pharmacol; 1993 Sep 15; 247(1):45-56. PubMed ID: 8258360
    [Abstract] [Full Text] [Related]

  • 3. Autoradiographic distribution of [3H]-(S)-zacopride-labelled 5-HT3 receptors in human brain.
    Parker RM, Barnes JM, Ge J, Barber PC, Barnes NM.
    J Neurol Sci; 1996 Dec 15; 144(1-2):119-27. PubMed ID: 8994113
    [Abstract] [Full Text] [Related]

  • 4. Characterisation and autoradiographic localisation of 5-HT3 receptor recognition sites identified with [3H]-(S)-zacopride in the forebrain of the rat.
    Barnes JM, Barnes NM, Champaneria S, Costall B, Naylor RJ.
    Neuropharmacology; 1990 Nov 15; 29(11):1037-45. PubMed ID: 2087255
    [Abstract] [Full Text] [Related]

  • 5. Labelling of 5-HT3 receptor recognition sites in the rat brain using the agonist radioligand [3H]meta-chlorophenylbiguanide.
    Steward LJ, West KE, Kilpatrick GJ, Barnes NM.
    Eur J Pharmacol; 1993 Oct 12; 243(1):13-8. PubMed ID: 8253120
    [Abstract] [Full Text] [Related]

  • 6. Quantitative autoradiographic mapping of 5-HT3 receptors in the rat CNS using [125I]iodo-zacopride and [3H]zacopride as radioligands.
    Laporte AM, Koscielniak T, Ponchant M, Vergé D, Hamon M, Gozlan H.
    Synapse; 1992 Apr 12; 10(4):271-81. PubMed ID: 1585260
    [Abstract] [Full Text] [Related]

  • 7. Characterization of desamino-5-[125I]iodo-3-methoxy-zacopride ([125I]MIZAC) binding to 5-HT3 receptors in the rat brain.
    Hewlett WA, Fridman S, Trivedi BL, Schmidt DE, de Paulis T, Ebert MH.
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Feb 12; 22(2):397-410. PubMed ID: 9608609
    [Abstract] [Full Text] [Related]

  • 8. [125I]S(-)-zacopride labels a novel 5-hydroxytryptamine sensitive recognition site in rat duodenum and ileum.
    Ge J, Towers P, Patel AC, Barnes NM.
    Eur J Pharmacol; 1996 Apr 04; 300(1-2):113-7. PubMed ID: 8741175
    [Abstract] [Full Text] [Related]

  • 9. Characterization of (S)-des-4-amino-3-[125I]iodozacopride ([125I]DAIZAC), a selective high-affinity radioligand for 5-hydroxytryptamine3 receptors.
    Hewlett WA, Trivedi BL, Zhang ZJ, de Paulis T, Schmidt DE, Lovinger DM, Ansari MS, Ebert MH.
    J Pharmacol Exp Ther; 1999 Jan 04; 288(1):221-31. PubMed ID: 9862774
    [Abstract] [Full Text] [Related]

  • 10. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.
    Wong EH, Clark R, Leung E, Loury D, Bonhaus DW, Jakeman L, Parnes H, Whiting RL, Eglen RM.
    Br J Pharmacol; 1995 Feb 04; 114(4):851-9. PubMed ID: 7773546
    [Abstract] [Full Text] [Related]

  • 11. Agonist interactions with 5-HT3 receptor recognition sites in the rat entorhinal cortex labelled by structurally diverse radioligands.
    Barnes JM, Barnes NM, Costall B, Jagger SM, Naylor RJ, Robertson DW, Roe SY.
    Br J Pharmacol; 1992 Feb 04; 105(2):500-4. PubMed ID: 1559139
    [Abstract] [Full Text] [Related]

  • 12. Autoradiographic localization of the [3H]-(S)-zacopride labelled 5-HT3 receptor in porcine brain.
    Fletcher S, Barnes NM.
    Neurosci Lett; 1999 Jul 09; 269(2):91-4. PubMed ID: 10430512
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and radiolabeling of (S)-4-amino-5-iodo-2-methoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamide, the active enantiomer of [125I]iodozacopride, and re-evaluation of its 5-HT3 receptor affinity.
    Hewlett WA, de Paulis T, Mason NS, Schmidt DE, Trivedi BL, Zhang ZJ, Ebert MH.
    Chem Pharm Bull (Tokyo); 1997 Dec 09; 45(12):2079-84. PubMed ID: 9433779
    [Abstract] [Full Text] [Related]

  • 14. Differential binding characteristics of agonists at 5-HT3 receptor recognition sites in NG108-15 neuroblastoma-glioma cells labelled by [3H]-(S)-zacopride and [3H]granisetron.
    Barnes JM, Barnes NM.
    Biochem Pharmacol; 1993 May 25; 45(10):2155-8. PubMed ID: 8390263
    [Abstract] [Full Text] [Related]

  • 15. [3H]zacopride: ligand for the identification of 5-HT3 recognition sites.
    Barnes NM, Costall B, Naylor RJ.
    J Pharm Pharmacol; 1988 Aug 25; 40(8):548-51. PubMed ID: 2907008
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and evaluation of [125I]-(S)-iodozacopride, a high affinity radioligand for 5HT3 receptors.
    Gehlert DR, Schober DA, Gackenheimer SL, Mais DE, Ladouceur G, Robertson DW.
    Neurochem Int; 1993 Oct 25; 23(4):373-83. PubMed ID: 8220179
    [Abstract] [Full Text] [Related]

  • 17. Evidence that the atypical 5-HT3 receptor ligand, [3H]-BRL46470, labels additional 5-HT3 binding sites compared to [3H]-granisetron.
    Steward LJ, Ge J, Bentley KR, Barber PC, Hope AG, Lambert JJ, Peters JA, Blackburn TP, Barnes NM.
    Br J Pharmacol; 1995 Sep 25; 116(2):1781-8. PubMed ID: 8528560
    [Abstract] [Full Text] [Related]

  • 18. Purification of 5-hydroxytryptamine3 receptors from porcine brain.
    Fletcher S, Barnes NM.
    Br J Pharmacol; 1997 Oct 25; 122(4):655-62. PubMed ID: 9375961
    [Abstract] [Full Text] [Related]

  • 19. The potent 5-HT3 receptor antagonist (R)-zacopride labels an additional high affinity site in the central nervous system.
    Kidd E, Bouchelet de Vendegies I, Levy JC, Hamon M, Gozlan H.
    Eur J Pharmacol; 1992 Jan 28; 211(1):133-6. PubMed ID: 1618262
    [Abstract] [Full Text] [Related]

  • 20. The (S)-isomer of [3H]zacopride labels 5-HT3 receptors with high affinity in rat brain.
    Waeber C, Pinkus LM, Palacios JM.
    Eur J Pharmacol; 1990 Jun 08; 181(3):283-7. PubMed ID: 2384135
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.